Corporate updates

We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.

With eyonis™ we are disrupting the management of serious diseases such as lung cancer and liver cancer. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis™ is currently under development.

Imaging Services for Clinical Trials

Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.

Learn More

Request a Demo

10/06/2015

Slideshow_Q3_2015
Download Slideshow_Q3_2015.pdf
Corporate presentation – Oct. 6, 2015, Investor’s luncheon – Paris (Slideshow in French only)
03/04/2015

Corporate Presentation Q1 2015
Download Corporate_presentation_Q12015.pdf
Cowen and Company 35th Annual Health Care Conference, March 2-4, 2015 Boston. MEDIAN corporate presentation, scheduled at 8:40 am ET, March 4, 2015.

Slideshow_Q3_2015

Corporate Presentation Q1 2015